Research on Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea
Nanoone Woman Underwear
Dysmenorrhea+5
+ Menstruation Disturbances
+ Neurologic Manifestations
Services Research Study
Summary
Study start date: October 1, 2011
Actual date on which the first participant was enrolled.The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS, ranging from zero (no pain) to ten (very severe pain). Subjects will be asked to use the VAS scoring system to record, on a provided sheet, their experienced menstrual pain level daily during menstrual bleeding for a total of three consecutive menstrual cycles.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.44 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Services Research Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 13 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: 1. Females aged below 40 years old. 2. Screened by inquiry and diagnosed as primary dysmenorrhea by gynaecologist with pelvic ultrasonography. 3. Female subject who is: * using adequate contraception since last menstruation and no plan for conception during the study. * non-lactating. * has negative pregnancy test (urine) within 14 days prior to the study. 4. Informed consent form signed. Exclusion Criteria: 1. Sensitivity to study product. 2. Patient has been diagnosed with secondary dysmenorrhea (defined as identifiable pelvic pathology). 3. Patient has clinically significant physical disability or abnormal findings on physical examination or laboratory testing judged by the investigator or co-investigator. 4. Participation of any clinical investigation during the last 30 days.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location